Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma.
Daponte A, Signoriello S, Maiorino L, Massidda B, Simeone E, Grimaldi AM, Caracò C, Palmieri G, Cossu A, Botti G, Petrillo A, Lastoria S, Cavalcanti E, Aprea P, Mozzillo N, Gallo C, Comella G, Ascierto PA; Southern Italy Cooperative Oncology Group (SICOG).
Daponte A, et al. Among authors: petrillo a.
J Transl Med. 2013 Feb 13;11:38. doi: 10.1186/1479-5876-11-38.
J Transl Med. 2013.
PMID: 23402397
Free PMC article.
Clinical Trial.